ABBV - AbbVie Inc.
收市後：
| 前收市價 | 136.44 |
| 開市 | 136.62 |
| 買盤 | 0.00 x 900 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 135.77 - 138.71 |
| 52 週波幅 | 134.09 - 168.11 |
| 成交量 | |
| 平均成交量 | 5,740,707 |
| 市值 | 243.401B |
| Beta 值 (5 年，每月) | 0.55 |
| 市盈率 (最近 12 個月) | 32.54 |
| 每股盈利 (最近 12 個月) | 4.24 |
| 業績公佈日 | 2023年7月27日 - 2023年7月31日 |
| 遠期股息及收益率 | 5.92 (4.34%) |
| 除息日 | 2023年4月13日 |
| 1 年預測目標價 | 165.17 |
Insider Monkey10 Best June Dividend Stocks To Buy
In this article, we discuss 10 best June dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best June Dividend Stocks To Buy. Apart from their significant contribution to the market’s overall returns, dividend stocks can also potentially […]
Insider MonkeyLouis Navellier’s 2023 Portfolio: 15 Growth Stocks to Watch
In this article, we discuss 15 growth stocks to watch in Louis Navellier’s 2023 portfolio. If you want to see more stocks in this selection, check out Louis Navellier’s 2023 Portfolio: 5 Growth Stocks to Watch. According to a report featured on Markets Insider in October 2022, Louis Navellier of Navellier & Associates said that the […]
Insider Monkey14 Best Biotech Stocks To Buy According To Hedge Funds
In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds. For more stocks, head on over to 5 Best Biotech Stocks To Buy According To Hedge Funds. Biotechnology is one of the hottest sectors these days. A handful of industries, such as space exploration, artificial intelligence, […]
Insider Monkey14 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and […]
Insider Monkey12 Cheap Dividend Stocks With High Yields
In this article, we discuss 12 cheap dividend stocks with high yields. You can skip our detailed analysis of value stocks and their past performance, and go directly to read 5 Cheap Dividend Stocks With High Yields. The Importance of Investing in Undervalued/Cheap Stocks Investing in value stocks is one of the most popular methods to […]
BenzingaFDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
The FDA has approved Epkinly (epcoritamab-bysp) as the first and only T-cell engaging bispecific antibody for adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. Epkinly is being co-developed and co-commercialized by Genmab A/S (NASDAQ: GMAB) and AbbVie Inc (NYSE: ABBV) as part of the companies' oncology collaboration. Epkinly features a dual-targeted approach continuously binding to T-cells and CD20+ lymphoma B-cell
BenzingaFDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
The FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active Crohn's disease patients with inadequate response or intolerance to one or more TNF blockers. This is the seventh FDA approval for Rinvoq across rheumatology, dermatology, and gastroenterology, where it is now indicated in both ulcerative colitis and Crohn's disease. The FDA noted that Rinvoq is the first oral drug. Though there are several other biologics already on the market to treat moderatel
Insider MonkeyHere’s Why Baron Health Care Fund Trimmed AbbVie (ABBV)
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The first quarter was difficult for the fund, as it failed to participate in the broader market rally and declined 3.69% compared to the 3.27% decline for the benchmark Russell […]
Insider MonkeyAnalysts Are Cutting Price Targets of These 10 Stocks
In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts. If you want to see more such stocks on the list, go directly to Analysts Are Cutting Price Targets of These 5 Stocks. Since mid-March, equity markets have experienced a notable rally, accompanied by a rise in bond prices […]
Insider MonkeyStates With the Lowest to Highest Capital Gains Tax Rate
In this article, we will take a look at states with the lowest to highest capital gains tax rates. You can skip our detailed analysis of capital gains taxes and the overall tax structure of different states, and go directly to read 10 States With the Lowest to Highest Capital Gains Tax Rate. Capital gains […]
Insider Monkey15 Biggest Immunotherapy Companies in the World
In this article, we will take a look at the 15 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 5 Biggest Immunotherapy Companies in the World. The immunotherapy industry is a rapidly growing field that is focused on developing treatments that harness the power […]
InvestorPlace7 Dividend Stocks That Will Pay You Through Any Market Turmoil
While there’s nothing quite as exciting as betting everything on a hot growth enterprise, prudent investors may want to consider the best dividend stocks for market crash. In late April, CNBC reported that investors face the threat of persistently higher inflation while simultaneously digesting a bleak economic outlook. If the Federal Reserve is truly making headway against inflation, recession fears should ease. Yet we’re often left with ambiguity. In such a situation, recession-proof dividend
Insider Monkey11 Best Canadian Dividend Stocks For Income Investors
In this article, we discuss 11 best Canadian dividend stocks for income investors. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Canadian Dividend Stocks For Income Investors. Inflation is hammering the globe and Canada is no exception. Inflation in Canada picked […]
InvestorPlace7 Dividend-Paying Large-Cap Stocks to Buy in May
Large-cap stocks are those that have a market capitalization above $10 billion and are synonymously known as big cap stocks. A company’s market capitalization is calculated by multiplying the share price by the number of shares outstanding. By that metric, all of the shares listed below qualify as large cap. Each stock listed below also pays out a dividend, providing shareholders with a dependable source of income. May is a great month to buy these companies despite the old adage to “sell in May
Insider Monkey12 Best Performing Dividend ETFs in 2023
In this article, we discuss 12 best performing dividend ETFs in 2023. You can skip our detailed analysis of dividend exchange-traded funds and their importance in today’s market, and go directly to read 5 Best Performing Dividend ETFs in 2023. Dividend-focused exchange-traded funds invest in stocks of companies that pay dividends. These ETFs can track […]
InvestorPlace7 Stock Upgrades and Downgrades Alerts You Cannot Ignore
Analyst stock upgrades and downgrades create powerful headlines that will move the underlying shares. Investors should take advantage of the price swings analysts create, especially when they make the wrong calls. Stock price changes are noisy. Investors may use the stock volatility to buy a stock at a temporary discount or sell on a spike. Among the seven companies discussed below, those with a strong revenue pipeline and earnings visibility are buys. In addition, they are typically large capit
Insider Monkey15 Best Income Stocks to Buy According to Analysts
In this article, we discuss 15 best income stocks according to analysts. You can skip our detailed analysis of dividend investing and the performance of dividend stocks in the past, and go directly to read 5 Best Income Stocks to Buy According to Analysts. Income investing is gaining popularity as investors look for trustworthy ways […]
- InvestorPlace
7 High-Yield Dividend Stocks to Buy and Hold Forever
The major indices have been trading in a broad range for over a year. This is frustrating for bulls and bears alike. And it serves as a reminder that markets aren’t rational. It has also initiated a flight to quality, which makes it a good time to look for high-yield dividend stocks to buy now. Dividend stocks deserve a place in any investor’s portfolio. Income-oriented investors benefit from receiving regular, and ideally growing, dividend payments every quarter. There are some dividend stocks
Insider Monkey15 Best Dividend Stocks of 2023
In this article, we discuss 15 best dividend stocks of 2023. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Dividend Stocks of 2023. Just when the stock market began recovering after suffering huge losses in 2022, the recent bank crisis drew […]
Insider Monkey10 Best May Dividend Stocks To Buy
In this article, we discuss 10 best May dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Best May Dividend Stocks To Buy. Dividend stocks have been a popular investment option for decades, providing investors with a steady stream […]
Insider MonkeyDividend Champions vs Aristocrats: 12 Under-the-Radar Stocks to Consider
In this article, we discuss 12 under-the-radar dividend champions to consider. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Champions vs Aristocrats: 5 Under-the-Radar Stocks to Consider. Dividend Aristocrats are companies in the S&P 500 Index that have increased their dividend payouts […]
- Insider Monkey
10 Best Dividend ETFs in 2023
In this article, we will take a look at the 10 best dividend ETFs in 2023. To see more such companies, go directly to 5 Best Dividend ETFs in 2023. Dividend stocks remain in the limelight as investors dig in for a long period of uncertainty amid the Federal Reserve’s fight against inflation. While upbeat […]
BenzingaWhy AbbVie Shares Are Trading Lower Today
AbbVie Inc (NYSE: ABBV) has reported Q1 adjusted EPS of $2.46, down 22.2% Y/Y, in line with the consensus. Overall sales decreased 9.7% Y/Y (down 8.3% on an operational basis) to $12.23 billion, beating the consensus of $12.17 billion. The immunology portfolio generated $5.59 billion in sales, down 9% (-7.8% on an operational basis). Humira sales decreased 25.2% to $3.54 billion. In Q4, Humira sales increased 4.6% to $5.56 billion. Skyrizi sales reached $1.36 billion (+44.7% Y/Y), and Rinvoq jum
- AASTOCKS
《美股業績》艾伯維(ABBV.US)首季業績符預期 股價跌逾7%
美國生物技術公司艾伯維(ABBV.US)公布，今年首季收入為122.3億美元(下同)，按年下跌9.7%，符合市場預期；每股經調整稀釋後盈利為2.46元，同樣與市場預期相符。 公司上調今年經調整稀釋後盈利指引，由原來的10.62元至11.02元，升至10.72元至11.12元。 業績公布後公司周四(27日)股價下挫，最新跌7.4%，報149.83元。(ek/m)~ 阿思達克財經新聞 網址: www.aastocks.com
Insider Monkey15 Best Large-Cap Dividend Growth Stocks To Buy Now
In this article, we discuss 15 best large-cap dividend growth stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Best Large-Cap Dividend Growth Stocks To Buy Now. The performance of large-cap stocks remained strong over the years. According to […]